FACEFI : Cardiac Fatigue During Intense Exercises - Pilot Study (FACEFI)

January 23, 2015 updated by: Rennes University Hospital

To attest if a cardiac fatigue appears (and to measure it if it does) during intense physical exercises in two groups of subjects:

  • Canoeists from a training center of the French canoeing team during an intensive session of three weeks of endurance training;
  • Young recruits in military school of officers in ground forces of the French army during an intensive.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rennes, France
        • Recruiting
        • CHU Rennes
        • Contact:
          • François FC Carré

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy men between 18 and 35 years old;
  • Giving their writing informed consent;
  • And affiliated to the French social security.

Exclusion Criteria:

  • To be a smoker.
  • To present any known pathology that forbids the realisation of any test, or that can alter the measurements: cardiovascular risk factors treated or not (diabetes, dyslipidaemia, arterial hypertension, obesity), cardiac arrhythmia, coronary disease, heart failure, cardiac pacemaker or defibrillator, valvular disease after surgery or not, kidneys failure with dialyse or not, kidney pulmonary cardiac or liver transplantation, chronic bronchopneumopathy, asthma, etc.
  • To take any medication that could alter autonomic nervous system or cardiovascular adaptation to maximal exercise (anti-arrhythmia, anti-hypertensive, anti-inflammatory,…).
  • Drinking exciting drinks (coffee or tee for example) in the 12h before the tests.
  • To be under legal protection (trusteeship, guardianship) or to be deprived of liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Canoeists
13 canoeists from a training center of the French canoeing team
Individual parameters of echocardiography and heart rate variability
Experimental: Military
10 young recruits in military school of officers in ground forces of the French army
Individual parameters of echocardiography and heart rate variability

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of classical echocardiographic parameters to attest systolic and diastolic functions
Time Frame: day 8 (canoeists) / day 5 (military)

Speckle tracking will also be used to get strain parameters of the left ventricle. Measure will by recording daily before, during, and after a period of intensive training, in order to attest possible cardiovascular effects of such periods.

Echocardiographic data will be recorded at rest and during a submaximal exercise.

day 8 (canoeists) / day 5 (military)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of classical heart rate variability parameters
Time Frame: day 8 (canoeists) / day 5 (military)

Measure will by recording daily before, during, and after a period of intensive training, in order to attest possible cardiovascular effects of such periods.

Measure will be recorded during 5 min resting and 5 min standing.

day 8 (canoeists) / day 5 (military)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: François FC Carré, CHU Rennes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

January 1, 2016

Study Completion

December 7, 2022

Study Registration Dates

First Submitted

April 28, 2014

First Submitted That Met QC Criteria

April 29, 2014

First Posted (Estimate)

April 30, 2014

Study Record Updates

Last Update Posted (Estimate)

January 26, 2015

Last Update Submitted That Met QC Criteria

January 23, 2015

Last Verified

April 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-A01524-41

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle; Fatigue, Heart

Clinical Trials on Tests

3
Subscribe